BIOMAT Database Logo BIOMAT Database Logo

Phase II study of PCNU in colorectal carcinoma. 1981

E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009150 Mustard Compounds Strong alkylating and immunosuppressive agents whose biological activity is based on the presence of bis(2-chloroethyl)- groups. Although otherwise structurally diverse, the compounds have in common the capacity to contribute alkyl groups to DNA. They are generally highly toxic but include among their number many widely used and effective antineoplastic agents. Compounds, Mustard
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
PCNU: phase II evaluation in advanced colorectal carcinoma.
June 1988, Investigational new drugs,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II trial of PCNU in breast carcinoma.
July 1989, Investigational new drugs,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
August 1984, American journal of clinical oncology,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II study of PCNU in the treatment of head and neck carcinoma.
February 1984, Cancer treatment reports,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma.
March 1987, Cancer treatment reports,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
PCNU in advanced adenocarcinoma of the ovary: a phase II study.
May 1983, Cancer treatment reports,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanoma.
January 1984, Cancer treatment reports,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II study of melphalan in colorectal carcinoma.
September 1978, Cancer treatment reports,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase I study of intracarotid PCNU.
January 1987, Journal of neuro-oncology,
E P Mitchell, and J Y Killen, and F P Smith, and L L Willis, and P S Schein, and P V Woolley
Phase II study of pyrazofurin in advanced colorectal carcinoma.
January 1977, Cancer treatment reports,
Copied contents to your clipboard!